Correlation Between Mobileye Global and BioNTech
Specify exactly 2 symbols:
By analyzing existing cross correlation between Mobileye Global Class and BioNTech SE, you can compare the effects of market volatilities on Mobileye Global and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mobileye Global with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mobileye Global and BioNTech.
Diversification Opportunities for Mobileye Global and BioNTech
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mobileye and BioNTech is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Mobileye Global Class and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Mobileye Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mobileye Global Class are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Mobileye Global i.e., Mobileye Global and BioNTech go up and down completely randomly.
Pair Corralation between Mobileye Global and BioNTech
Given the investment horizon of 90 days Mobileye Global Class is expected to under-perform the BioNTech. In addition to that, Mobileye Global is 1.83 times more volatile than BioNTech SE. It trades about -0.08 of its total potential returns per unit of risk. BioNTech SE is currently generating about -0.13 per unit of volatility. If you would invest 11,000 in BioNTech SE on December 25, 2024 and sell it today you would lose (1,930) from holding BioNTech SE or give up 17.55% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 98.33% |
Values | Daily Returns |
Mobileye Global Class vs. BioNTech SE
Performance |
Timeline |
Mobileye Global Class |
BioNTech SE |
Mobileye Global and BioNTech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mobileye Global and BioNTech
The main advantage of trading using opposite Mobileye Global and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mobileye Global position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.Mobileye Global vs. Quantumscape Corp | Mobileye Global vs. Innoviz Technologies | Mobileye Global vs. Aeva Technologies, Common | Mobileye Global vs. Hyliion Holdings Corp |
BioNTech vs. Hana Microelectronics PCL | BioNTech vs. ecotel communication ag | BioNTech vs. ELECTRONIC ARTS | BioNTech vs. TELECOM ITALIA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
CEOs Directory Screen CEOs from public companies around the world |